You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 7634 results
  1. A2A Adenosine Receptor Agonist for the Treatment of IBD

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents on the formulation and use of a family of potent and highly selective agonists of A2A adenosin

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  2. A1 adenosine agonist: antinociceptive effects

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The current Phase I SBIR Grant application by Inotek Pharmaceuticals Corporation proposes to test the antinociceptive effect of a novel A1 receptor agonist in rat models. As preliminary data we present evidence in

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. 2-5A Antisense for Degradation of SARS Coronavirus RNA

    SBC: RIDGEWAY BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Severe acute respiratory syndrome (SARS) is a newly recognized illness that has rapidly spread throughout Asia, North America and Europe. SARS has been found to be a highly infectious disease with high mortality,

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Ab Alphavirus Replicon Vaccine against Cytomegalovirus

    SBC: GREER LABORATORIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objectives of the proposed research are to develop further an alphavirus replicon particle vaccine against human cytomegalovirus (CMV). CMV causes a chronic, persistent infection and is an important cause of morbi

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Abatement of Nitrous Oxide Emissions by Low Temperature Catalytic Decomposition

    SBC: SIENNA TECHNOLOGIES, INC.            Topic: 45

    75602-Nitric acid production is currently the largest source of nitrous oxide emissions in the chemical industry. Reductions in these emissions are urgently required because nitrous oxide is both a strong greenhouse gas and an ozone layer depleter. Although measures exist to eliminate nitrous oxide emissions from adipic acid plants, they cannot be applied to eliminate nitrous oxide emissions fro ...

    SBIR Phase I 2004 Department of Energy
  6. ABEL: an Adaptive Belief Engine for Satellite Cluster Data Fusion

    SBC: INTERFACE & CONTROL SYSTEMS, INC.            Topic: AF02062

    Data Fusion has emerged as a critical technology to be developed and deployed for military projects encompassing Space Situational Awareness, and Offensive/Defensive Counterspace to increase the warfighter's ability to identify, characterize, geo-locate and assess attacks. Fusion has also been identified as a major risk to be mitigated for the NASA/Air Force Joint Space Launch Initiative (SLI) Re ...

    SBIR Phase II 2004 Department of DefenseAir Force
  7. Aberration-Corrected Retinal Spot Projector and Imager (ARSPI)

    SBC: AGILOPTICS            Topic: AF04073

    Intellite, Incorporated will team with the Optical Sciences Center at the University of Arizona to develop an adaptive optics system that will project a diffraction-limited spot on the retina by pre-correcting the laser beam for all significant optical aberrations of the specific eyeball under test. The system will use real-time feedback from a low-power laser reflected from the retina to measure ...

    SBIR Phase I 2004 Department of DefenseAir Force
  8. A Biologically Inspired Morphing Micro Air-Land Vehicle (MMALV)

    SBC: BIOROBOTS, LLC            Topic: AF04177

    BioRobots, Case Western Reserve University, and The University of Florida have partnered with Boeing Phantom Works to develop a Morphing Micro Air-Land Vehicle (MMALV) to enhance military intelligence gathering capabilities in battlespace environments. Building on landmark successes in micro air vehicle fabrication at The University of Florida and micro robot implementation at Case Western Reserve ...

    SBIR Phase I 2004 Department of DefenseAir Force
  9. A biosensor to detect ERE-binding proteins in cancer

    SBC: IA, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Biosensors provide rapid data containing information on molecular interactions that are not easily available using equilibrium assays or histochemical methods. This study will be the first of a series with long-term ob

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Abrasion-Resistant, Electrically Conductive Transparent Coatings for Polycarbonate

    SBC: NANOSONIC INC.            Topic: N02187

    The objective of this Navy Phase II program is to optimize the electrical conductivity, uniformity, transmission, chemical and abrasion resistance of transparency coatings developed during Phase I. NanoSonic will collaborate with a leading Aeronautics corporation and transparency supplier to upscale and commercialize such coatings. Well defined monodisperse metal nanoparticles will self assemble ...

    SBIR Phase II 2004 Department of DefenseNavy
US Flag An Official Website of the United States Government